Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Style
News
Style
News
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
About – Contact
Institutional Investors
Analysts
Side Stories
Disclaimer
Search
Search
Login
HOME
Universe A-Z
PSYCH STOCK NEWS
PSYCH NEWS
RESEARCH
TESTIMONIALS
CLINICAL TRIALS
CONFERENCES
2023 PSYCHEDELIC INVESTOR CONFERENCE
SEARCH BY SYMBOL
Home
Search
Search
INTERVIEW
Interview: Dr. Deborah Nash, Ibogaine and Miami Based DemeRX.
Editor | Curator
-
June 4, 2023
2023 Watch List
Shark Tank’s Kevin Harrington Invests In Psychedelics Company Psycheceutical (BWVI). Forbes
Editor | Curator
-
May 15, 2023
2023 Watch List
Adding Psycheceutical Bioscience (BWVI) $0.14 to Watch List. (Ketamine.)
Editor | Curator
-
May 15, 2023
INTERVIEW
Ketamine and Yale University
Editor | Curator
-
May 15, 2023
CLINICAL TRIALS
Johns Hopkins Receives $20M From Roland R. Griffiths Ph.D. Professorship Fund For Psychedelic Research
Editor | Curator
-
May 9, 2023
2023 Watch List
Is ATAI Live Sciences (ATAI) $2.00, Finally Turning?
Editor | Curator
-
April 24, 2023
INTERVIEW
PSYCHECEUTICAL TO CONDUCT THE FIRST EVER PHASE I AND II CLINICAL TRIALS OF A NOVEL KETAMINE TOPICAL CREAM TO TREAT PTSD
Editor | Curator
-
February 22, 2023
Subscribe for Free!
Editor | Curator
-
August 9, 2021
2021 Psychedelic Investor Guide.
Editor | Curator
-
August 8, 2021
2023 Psychedelic Investor Conference
Editor | Curator
-
August 7, 2021
ALL PSYCHEDELIC AND PSYCHEDELIC STOCK NEWS
Interview: Dr. Deborah Nash, Ibogaine and Miami Based DemeRX.
INTERVIEW
Editor | Curator
-
June 4, 2023
Partnered with ATAI Life Sciences ATAI. Amazing Interview. "I said there's no way that you can take one dose of Ibogaine...
View Post
Psychedelic Marketing: Adrian Morrison
Uncategorized
Editor | Curator
-
May 24, 2023
https://youtu.be/EZPAoTFqaro
View Post
Shark Tank’s Kevin Harrington Invests In Psychedelics Company Psycheceutical (BWVI). Forbes
2023 Watch List
Editor | Curator
-
May 15, 2023
Mike Zapolin, Kevein Harrington and CEO Chad Harman Another Shark Tank original has invested in the psychedelic industry.
View Post
Adding Psycheceutical Bioscience (BWVI) $0.14 to Watch List. (Ketamine.)
2023 Watch List
Editor | Curator
-
May 15, 2023
Above: Lamar Odom and Psychedelic Advocate Mike Zappy Zapolin. We’re Calling a Sector Bottom, and Psycheceutical (BWVI)...
View Post
Ketamine and Yale University
INTERVIEW
Editor | Curator
-
May 15, 2023
Depression is one of the most common and most debilitating mental health disorders, affecting some 17 million adults in the US. It...
View Post
Johns Hopkins Receives $20M From Roland R. Griffiths Ph.D. Professorship Fund For Psychedelic Research
CLINICAL TRIALS
Editor | Curator
-
May 9, 2023
John Hopkins Center for Psychedelic and Consciousness Research Johns Hopkins University academics just a got a boost in their funding thanks to...
View Post
Is ATAI Live Sciences (ATAI) $2.00, Finally Turning?
2023 Watch List
Editor | Curator
-
April 24, 2023
After Dropping 94% From Post IPO high from $19.45, a loss of exceeding $3 billion and change, ATAI is in the early...
View Post
PSYCHECEUTICAL TO CONDUCT THE FIRST EVER PHASE I AND II CLINICAL TRIALS OF A NOVEL KETAMINE TOPICAL CREAM TO TREAT PTSD
INTERVIEW
Editor | Curator
-
February 22, 2023
Psycheceutical enters into agreement with iNGENū to conduct human clinical trials of NeuroDirect™ ketamine topical in Australia
View Post
The Kahner Global Cannabis & Psychedelics Investment Summit.
PSYCH NEWS
Editor | Curator
-
February 15, 2023
Kahner Global’s 8th annual Cannabis & Psychedelics Investment Summit When:...
View Post
Awakn Life Sciences (AWKNF) $0.30 Announces Signing of Lease for Second Clinic in Norway.
CLINICS
Editor | Curator
-
December 2, 2022
Trondheim in central Norway will be the location of Awakn's 4th clinic LIVE QUOTE
View Post
Silo Pharma (SILO) Issues Letter to Shareholders
2023 Watch List
Editor | Curator
-
December 2, 2022
Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets Combining Traditional Therapeutics with Psychedelic Medicine LIVE QUOTE
View Post
Silo Pharma (SILO) $3.36 Achieves New Milestone for SP-26 Therapeutic -Initiates IND Enabling Study of Topical Ketamine Formulation
Featured
Editor | Curator
-
November 11, 2022
View Post ENGLEWOOD CLIFFS, NJ, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage...
View Post
Stressed Wall Street Execs Flock to Ketamine Therapy Sessions (NY Post)
CLINICS
Editor | Curator
-
October 23, 2022
Therapy’s a trip for these Wall Street executives. Wealthy stock traders are flocking to a Manhattan-based ketamine therapy practice that doles out...
View Post
1
2
3
...
9
Page 1 of 9
KetaDash
Ketamine at Home Treatments
RESEARCH
Most Popular
Interview: Dr. Deborah Nash, Ibogaine and Miami Based DemeRX.
INTERVIEW
Editor | Curator
-
June 4, 2023
Partnered with ATAI Life Sciences ATAI. Amazing Interview. "I said there's no way that you can take one dose of Ibogaine...
Psychedelic Marketing: Adrian Morrison
Uncategorized
Editor | Curator
-
May 24, 2023
https://youtu.be/EZPAoTFqaro
Shark Tank’s Kevin Harrington Invests In Psychedelics Company Psycheceutical (BWVI). Forbes
2023 Watch List
Editor | Curator
-
May 15, 2023
Mike Zapolin, Kevein Harrington and CEO Chad Harman Another Shark Tank original has invested in the psychedelic industry.
Trending Now
Interview: Dr. Deborah Nash, Ibogaine and Miami Based DemeRX.
Psychedelic Marketing: Adrian Morrison
Shark Tank’s Kevin Harrington Invests In Psychedelics Company Psycheceutical (BWVI). Forbes
Adding Psycheceutical Bioscience (BWVI) $0.14 to Watch List. (Ketamine.)
Ketamine and Yale University
LARGE CAP PSYCHEDELIC STOCKS
Is ATAI Live Sciences (ATAI) $2.00, Finally Turning?
Editor | Curator
-
April 24, 2023
Australian Icannex (IHL:ASX) Headed to NASDAQ?
Editor | Curator
-
February 10, 2022
Small Pharma (DMT, DMTTF) $0.46 a Small and Extremely Interesting Psychedelic Company.
Editor | Curator
-
November 4, 2021
PSYCHEDELIC FUNDS AND ETFS
AdvisorShares Psychedelics ETF (PSIL)
Editor | Curator
-
September 21, 2021
Novamind (NVMDF) Announces Inclusion in NYSE Listed AdvisorShares Psychedelics ETF (PSIL)
Editor | Curator
-
September 20, 2021
Horizons Psychedelic Index ETF.
Editor | Curator
-
September 17, 2021